Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
US Army
Argus Health

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for Patent: 7,896,264

« Back to Dashboard

Which drugs does patent 7,896,264 protect, and when does it expire?


Protection for SPIRIVA RESPIMAT has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has thirty-five patent family members in thirty-two countries.

Summary for Patent: 7,896,264

Title:Microstructured high pressure nozzle with built-in filter function
Abstract: A microstructured nozzle consists of a number of channels produced by microstructuring a plate-shaped member. In the nozzle the channels are located between projections which are arranged side by side in rows and project from a base plate. This microstructured base plate is covered with a cover plate. The channels are narrowly defined in terms of shape, cross sectional area and length. The nozzle contains a filter as the primary structure and a secondary structure downstream of the filter. The nozzle is used, for example, with an atomiser which produces an aerosol from a fluid containing a medicament.
Inventor(s): Eicher; Joachim (Dortmund, DE), Geser; Johannes (Ingelheim, DE), Hausmann; Matthias (Dortmund, DE), Reinecke; Holger (Dortmund, DE)
Assignee: Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE)
Application Number:10/877,134
Patent Claim Types:
see list of patent claims

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Boehringer IngelheimCOMBIVENT RESPIMATalbuterol sulfate; ipratropium bromideSPRAY, METERED;INHALATION021747-001Oct 7, 2011RXYesYes► Subscribe► SubscribeY► Subscribe
Boehringer IngelheimSTIOLTO RESPIMATolodaterol hydrochloride; tiotropium bromideSPRAY, METERED;INHALATION206756-001May 21, 2015RXYesYes► Subscribe► SubscribeY► Subscribe
Boehringer IngelheimSTRIVERDI RESPIMATolodaterol hydrochlorideSPRAY, METERED;INHALATION203108-001Jul 31, 2014RXYesYes► Subscribe► SubscribeY► Subscribe
Boehringer IngelheimSPIRIVA RESPIMATtiotropium bromideSPRAY, METERED;INHALATION021936-002Sep 15, 2015RXYesNo► Subscribe► SubscribeY► Subscribe
Boehringer IngelheimSPIRIVA RESPIMATtiotropium bromideSPRAY, METERED;INHALATION021936-001Sep 24, 2014RXYesYes► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 7,896,264

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany103 30 370Jun 30, 2003
03027927Dec 04, 2003
03027927Dec 4, 2003

International Patent Family for Patent: 7,896,264

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Portugal1641569► Subscribe
Peru00262005► Subscribe
New Zealand544886► Subscribe
Norway20060412► Subscribe
Malaysia136755► Subscribe
MexicoPA05013878► Subscribe
South Korea20060032162► Subscribe
Japan4933252► Subscribe
Japan2008529754► Subscribe
Israel172461► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Farmers Insurance
Express Scripts
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: